Trial Search Results
Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers
The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.
Stanford is currently not accepting patients for this trial.
Lead Sponsor:
Stanford University
Stanford Investigator(s):
Eligibility
Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical
resection of their tumors Exclusion Criteria:- Patients without non-small cell lung cancer
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Rachel Freiberg
6507254777